← Eichor
Study identifier: NCT07698886 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Condition: HPV (Human Papillomavirus)-Associated · Genital Warts  ·  Sponsor: KTH Biopharma

PhasePhase 2
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

This description comes directly from the study's public registry record.

Talk to the study team

Thanh Tam Tran, MD  ·  +84383744842  ·  Tranthanhtam.fmh@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Dermatology Hospital, Hanoi, Vietnam.Hanoi, None (International), VietnamRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07698886